The Use of an IL-1 Receptor Antagonist Peptide to Control Inflammation in the Treatment of Corneal Limbal Epithelial Stem Cell Deficiency

Corneal limbal stem cell deficiency (LSCD) may be treated using ex vivo limbal epithelial stem cells (LESCs) derived from cadaveric donor tissue. However, continuing challenges exist around tissue availability, inflammation, and transplant rejection. Lipopolysaccharide (LPS) or recombinant human IL-...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biomed Res Int
Main Authors: Fok, E., Sandeman, S. R., Guildford, A. L., Martin, Y. H.
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2015
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4330955/
https://ncbi.nlm.nih.gov/pubmed/25705668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/516318
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares